Search Results

Optimization of CRBN Ligand and Linker Drives Discovery of APH003, an Orally Bioavailable IRAK4 PROTAC Degrader11. August 2026

Author: AiFChem

Comment:  0

Metal-Free Alkynyl Boron Platform for Modular Synthesis of Stereodefined Allylamines4. August 2026

Author: AiFChem

Comment:  0

Targeting ERAP1: The Discovery and Optimization of Allosteric Inhibitor GSK2354. August 2026

Author: AiFChem

Comment:  0

Discovery of SD-2301: A Single-Dose VHL-Recruiting STAT3 PROTAC Degrader1. August 2026

Author: AiFChem

Comment:  0

tert-Butyl Group in Drug Design: Metabolic Liabilities and Bioisosteric Strategies11. Juni 2026

Author: AiFChem

Comment:  0

Unlocking Direct C–S Bonds: Radical C–SuFEx Ligation of Sulfonyl and Sulfonimidoyl Fluorides with Alkenes and Alkynes2. Juni 2026

Author: AiFChem

Comment:  0

Oxetane as a Strategic Bioisostere: Improving ADMET Profiles and Pharmacokinetics in Small Molecule Design29. Mai 2026

Author: AiFChem

Comment:  0

PROTAC Technology Enters Its Commercialization Era: Key Molecular Building Blocks for Your Next Breakthrough21. Mai 2026

Author: AiFChem

Comment:  0

Discovery of INCB191358: A Potent and Selective DGKα/ζ Dual Inhibitor13. Mai 2026

Author: AiFChem

Comment:  0

Efficient Synthesis Guide: 5 Essential Building Blocks for Modern Drug Discovery9. Mai 2026

Author: AiFChem

Comment:  0

Total: 84

10 items / page

12345 … 9